The first malaria treatment for babies and very young children of 2 months up to 5 years was approved for use by Swiss agency for therapeutic products, Swissmedic, in early July 2025. Until now, babies and very young children ...
Jul 29, 2025
0
0
Ivermectin administered to the whole population significantly reduces malaria transmission, offering new hope in the fight against the disease.
Jul 23, 2025
0
25
A major international study led by Liverpool School of Tropical Medicine (LSTM) has confirmed that the drug used to prevent malaria in pregnancy continues to protect babies' health, despite malaria parasites developing high ...
Jul 17, 2025
0
0
Researchers at Karolinska Institutet have identified over 250 proteins that are strongly affected by malaria, which could help predict the severity of the disease and thus enable faster treatment for the most critical patients.
Jul 14, 2025
0
2
Brazilian researchers have discovered chemical compounds in marine sponges that have the potential to eliminate the malaria parasite, including strains that are resistant to conventional antimalarial drugs. The research results ...
Jul 9, 2025
0
0
The first malaria treatment for newborns and young infants has received approval from Swiss health regulators, with eight African countries poised to roll the drug out rapidly, pharmaceutical giant Novartis said Tuesday.
Jul 8, 2025
0
0
Suriname has become the first Amazonian country to eliminate malaria after 70 years of fighting the mosquito-borne disease, the World Health Organization (WHO) announced Monday.
Jul 1, 2025
0
0
Malaria cases in the Asia Pacific region have surged in the last few years, reaching 4.8 million in 2024 and putting the region further off track to reaching its elimination goal by 2030, a summit heard.
Jun 24, 2025
0
0
Malaria is a life-threatening disease affecting people globally. It is spread by mosquitoes carrying Plasmodium parasites that infect and hide in red blood cells, making them difficult for the immune system to detect.
Jun 24, 2025
0
9
Monoclonal antibodies provide protection against a wide range of infectious microbes, and now, in a series of elegant laboratory experiments, scientists have uncovered how a pair of these lab-engineered molecules fight malaria.
